biotech · Glanzmann Thrombasthenia · Von Willebrand Disease (VWD) · COAG
Hemab Therapeutics Holdings
Hemab Therapeutics Holdings clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
frederiksberg, DK HQ
2020 Founded
90 Employees
Public company Type
COAG · NYSE Ticker
Company details
- Status
- Public
- HQ
- frederiksberg, DK
- Founded
- 2020
- Employees
- 90
- Programs
- 4
- Drugs
- 0
- Patents
- 0
Hemab Therapeutics Holdings projects
0 ClinicalTrials.gov programs sponsored by Hemab Therapeutics Holdings.
Hemab Therapeutics Holdings has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Hemab Therapeutics Holdings have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.